Related Experiment Video

Updated: Mar 26, 2026

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
06:03

Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression

Published on: January 19, 2019

18.5K

Reduced PDCD4 Expression Promotes Cell Growth Through PI3K/Akt Signaling in Non-Small Cell Lung Cancer

Yan Zhen1, Dongming Li, Wen Li

  • 1Institute of Respiratory Diseases, Affiliated Hospital of Guangdong Medical College, Zhanjiang, PR China.

Oncology Research
|January 24, 2016
PubMed

Insights

Programmed cell death 4 (PDCD4) loss promotes non-small cell lung cancer (NSCLC) growth by activating PI3K/Akt signaling. Restoring PDCD4 may offer a new therapeutic strategy for NSCLC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Programmed cell death 4 (PDCD4) is often lost in various cancers, contributing to tumor progression.
  • The specific role and molecular mechanisms of PDCD4 in non-small cell lung cancer (NSCLC) are not well understood.

Purpose of the Study:

  • To investigate the role of PDCD4 in NSCLC progression.
  • To elucidate the molecular mechanisms by which PDCD4 regulates cell growth in NSCLC.

Main Methods:

  • Quantitative analysis of PDCD4 mRNA expression in NSCLC tissues.
  • In vitro experiments involving induced PDCD4 expression and PDCD4 knockdown.
  • Investigation of the PI3K/Akt signaling pathway using specific inhibitors (Ly294002 and MK2206).

Main Results:

  • PDCD4 mRNA expression was significantly downregulated in NSCLC tissues.
  • Upregulating PDCD4 inhibited NSCLC cell growth, proliferation, and cell cycle progression.
  • Knocking down PDCD4 promoted NSCLC cell growth and proliferation.
  • PDCD4 inactivated the PI3K/Akt pathway, decreasing levels of pPI3K, pAkt, CCND1, and CDK4.

Conclusions:

  • PDCD4 functions as a tumor suppressor in NSCLC by inhibiting cell growth via the PI3K/Akt signaling pathway.
  • PDCD4 represents a potential therapeutic target for NSCLC treatment.

More Related Videos

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment11:13

Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment

Published on: June 9, 2023

2.5K
The Soft Agar Colony Formation Assay08:01

The Soft Agar Colony Formation Assay

Published on: October 27, 2014

114.3K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K